192 related articles for article (PubMed ID: 32170048)
21. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
Wang RJ; Zheng YH; Wang P; Zhang JZ
Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772
[TBL] [Abstract][Full Text] [Related]
22. Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer.
Li M; Zhang Q; Wu L; Jia C; Shi F; Li S; Peng A; Zhang G; Song X; Wang C
Oncol Rep; 2014 Apr; 31(4):1961-7. PubMed ID: 24549225
[TBL] [Abstract][Full Text] [Related]
23. Serum microRNA-135a as a diagnostic biomarker in non-small cell lung cancer.
Zou Y; Jing C; Liu L; Wang T
Medicine (Baltimore); 2019 Dec; 98(50):e17814. PubMed ID: 31852062
[TBL] [Abstract][Full Text] [Related]
24. Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia.
Hanafi AR; Jayusman AM; Alfasunu S; Sadewa AH; Pramono D; Heriyanto DS; Haryana SM
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):321-332. PubMed ID: 32283582
[TBL] [Abstract][Full Text] [Related]
25. Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.
Cui EH; Li HJ; Hua F; Wang B; Mao W; Feng XR; Li JY; Wang X
Acta Pharmacol Sin; 2013 Feb; 34(2):309-13. PubMed ID: 22983388
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
Liu W; Liu J; Zhang Q; Wei L
Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
[TBL] [Abstract][Full Text] [Related]
27. Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study.
Pastuszak-Lewandoska D; Kordiak J; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz JM; Antczak A; Górski P; Brzeziańska-Lasota E
Med Oncol; 2016 Aug; 33(8):96. PubMed ID: 27447710
[TBL] [Abstract][Full Text] [Related]
28. Serum microRNA biomarkers for detection of non-small cell lung cancer.
Hennessey PT; Sanford T; Choudhary A; Mydlarz WW; Brown D; Adai AT; Ochs MF; Ahrendt SA; Mambo E; Califano JA
PLoS One; 2012; 7(2):e32307. PubMed ID: 22389695
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
[TBL] [Abstract][Full Text] [Related]
30. Serum miR-185 Is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer.
Liu J; Han Y; Liu X; Wei S
Technol Cancer Res Treat; 2020; 19():1533033820973276. PubMed ID: 33251978
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer.
Liu F; Li T; Hu P; Dai L
Dis Markers; 2021; 2021():8819934. PubMed ID: 33763157
[TBL] [Abstract][Full Text] [Related]
32. Serum microRNA-135a downregulation as a prognostic marker of non-small cell lung cancer.
Zhang YK; Sun B; Sui G
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525941
[TBL] [Abstract][Full Text] [Related]
33. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.
Ulivi P; Foschi G; Mengozzi M; Scarpi E; Silvestrini R; Amadori D; Zoli W
Int J Mol Sci; 2013 May; 14(5):10332-42. PubMed ID: 23681013
[TBL] [Abstract][Full Text] [Related]
34. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
36. Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
Roth C; Stückrath I; Pantel K; Izbicki JR; Tachezy M; Schwarzenbach H
PLoS One; 2012; 7(6):e38248. PubMed ID: 22675530
[TBL] [Abstract][Full Text] [Related]
37. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
[TBL] [Abstract][Full Text] [Related]
38. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
39. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
40. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer.
Zhu W; He J; Chen D; Zhang B; Xu L; Ma H; Liu X; Zhang Y; Le H
PLoS One; 2014; 9(2):e87780. PubMed ID: 24523873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]